SCHEMBL26298680

SCHEMBL26298680

CC(C)CCCn1c(-c2ccccc2)cc2ccc(OC(C)(C)C)cc21

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 2/20 0.46
MTNR1B P49286 2/20 0.46
MCL1 Q07820 2/20 0.41
GRIK1 P39086 1/20 0.40
GRIK2 Q13002 1/20 0.40
ALDH1A1 P00352 3/20 0.39
HASPIN Q8TF76 1/20 0.37
KMT2A Q03164 2/20 0.37
ACLY P53396 2/20 0.36
BACE1 P56817 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
KDM4E B2RXH2 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HSD17B10 Q99714 2/20 0.34
NR1H2 P55055 1/20 0.34
MEN1 O00255 1/20 0.33
GLA P06280 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23893555 0.89 MTNR1A (0.45) MTNR1AMTNR1BMCL1GRIK1GRIK2
SCHEMBL21735692 0.88 MTNR1A (0.58) MTNR1AMTNR1BGRIK1GRIK2ALDH1A1
SCHEMBL23395731 0.87 MTNR1A (0.44) MTNR1AMTNR1BMCL1GRIK1GRIK2
SCHEMBL23893484 0.87 ALDH1A1 (0.43) MTNR1AMTNR1BGRIK1GRIK2ALDH1A1
SCHEMBL26298661 0.87 MTNR1A (0.43) MTNR1AMTNR1BMCL1GRIK1GRIK2
SCHEMBL26292366 0.85 MTNR1A (0.47) MTNR1AMTNR1BMCL1GRIK1GRIK2
SCHEMBL23395645 0.81 MTNR1A (0.44) MTNR1AMTNR1BMCL1GRIK1GRIK2
SCHEMBL22628833 0.81 ALDH1A1 (0.57) MTNR1AMTNR1BGRIK1GRIK2ALDH1A1
SCHEMBL21735536 0.81 ALDH1A1 (0.45) MTNR1AMTNR1BGRIK1GRIK2ALDH1A1
SCHEMBL23395730 0.80 MTNR1A (0.42) MTNR1AMTNR1BMCL1GRIK1GRIK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11753387-B2 Compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11753387-B2 Compounds for optically active devices PDE6C, PDE6A, PDE6D MTNR1A 1345/4885MTNR1B 837/4885MCL1 4766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.